eudragit-e has been researched along with cellulose in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itai, S; Iwao, Y; Miyagishima, A; Shiino, K | 1 |
| Goyanes, A; MartÃnez-Pacheco, R; Souto, C | 1 |
| He, D; Liao, H; Liu, G; Tan, Q; Wang, H; Wu, J; Yin, H; Zhang, J; Zhang, L | 1 |
| Beak, IH; Kim, MS | 1 |
| Basit, AW; Mwesigwa, E | 1 |
| Hoon Jeong, S; Park, ES; Park, SJ; Seo, HJ; Thapa, P | 1 |
1 trial(s) available for eudragit-e and cellulose
| Article | Year |
|---|---|
Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation.
Topics: Administration, Oral; Adult; Animals; Anticholesteremic Agents; Biological Availability; Cellulose; Cholesterol Ester Transfer Proteins; Double-Blind Method; Drug Carriers; Drug Compounding; Drug Development; Excipients; Female; Humans; Hydrocarbons, Fluorinated; Macaca mulatta; Male; Mannitol; Middle Aged; Models, Biological; Oxazoles; Permeability; Poloxamer; Polymethacrylic Acids; Proof of Concept Study; Solubility; Tablets; Young Adult | 2018 |
5 other study(ies) available for eudragit-e and cellulose
| Article | Year |
|---|---|
Optimization of a novel wax matrix system using aminoalkyl methacrylate copolymer E and ethylcellulose to suppress the bitter taste of acetaminophen.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Cellulose; Chemistry, Pharmaceutical; Dosage Forms; Drug Compounding; Excipients; Glycerides; Hydrogen-Ion Concentration; Kinetics; Models, Chemical; Particle Size; Perceptual Masking; Polymethacrylic Acids; Principal Component Analysis; Regression Analysis; Solubility; Taste; Technology, Pharmaceutical; Viscosity; Waxes | 2010 |
Co-processed MCC-Eudragit® E excipients for extrusion-spheronization.
Topics: Cellulose; Compressive Strength; Drug Compounding; Excipients; Hydrochlorothiazide; Methacrylates; Methylmethacrylates; Microscopy, Electron, Scanning; Particle Size; Powder Diffraction; Solubility; Spectrophotometry, Infrared; Surface Properties; X-Ray Diffraction | 2011 |
Novel taste-masked orally disintegrating tablets for a highly soluble drug with an extremely bitter taste: design rationale and evaluation.
Topics: Animals; Cellulose; Chemical Phenomena; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Excipients; Female; Flavoring Agents; Humans; Kinetics; Male; Models, Chemical; Polymethacrylic Acids; Povidone; Pyridostigmine Bromide; Rabbits; Random Allocation; Saliva; Solubility; Tablets; Taste; Therapeutic Equivalency | 2013 |
Improved supersaturation and oral absorption of dutasteride by amorphous solid dispersions.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; 5-alpha Reductase Inhibitors; Administration, Oral; Animals; Azasteroids; beta-Cyclodextrins; Cellulose; Dutasteride; Excipients; Hypromellose Derivatives; Male; Methylcellulose; Methylmethacrylates; Povidone; Rats; Rats, Sprague-Dawley; Solubility | 2012 |
An investigation into moisture barrier film coating efficacy and its relevance to drug stability in solid dosage forms.
Topics: Aspirin; Cellulose; Chemistry, Pharmaceutical; Drug Stability; Methacrylates; Polymers; Polymethacrylic Acids; Polyvinyls; Stearic Acids; Tablets; Water | 2016 |